RNA Structure

RNA structure refers to the three dimensional conformation of ribonucleic acid molecules, determined by their sequence and the folding of the polymer through canonical and noncanonical base pairing, stacking, and other interactions. This guide is intended for researchers, bioinformaticians, and students who need a practical framework for understanding, analyzing, and interpreting RNA structure from primary sequence data through to functional modeling. An authoritative overview of RNA structural principles is available from the NCBI Bookshelf [1].

Understanding RNA structure is critical because it governs functions such as catalysis, translation regulation, and molecular recognition. Structural analysis frequently begins with secondary structure prediction and progresses toward tertiary modeling or experimental validation using biochemical or biophysical methods. The EMBL EBI Training portal provides excellent resources for learning the bioinformatics approaches used in RNA structural analysis [2].

At a Glance

Core Concepts of RNA Structure

RNA molecules are built from ribonucleotides containing adenine, uracil, guanine, and cytosine. The primary sequence dictates the folding landscape. Secondary structure elements include stems (helices), hairpin loops, internal loops, bulges, and multibranch junctions. These elements are constrained by thermodynamic stability and kinetic folding pathways. Tertiary structure involves interactions such as coaxial stacking, base triples, and pseudoknots that compact the molecule into a functional shape.

RNA structure is hierarchical: the secondary structure often forms first and then guides tertiary folding. This property allows reliable computational prediction of secondary structure from a single sequence or an alignment. The Galaxy Training Network offers hands on workflows for predicting RNA secondary structure from high throughput sequencing data [3]. For deeper analysis, the Bioconductor project provides R packages such as RNAfold and R4RNA that integrate structure prediction with statistical modeling [4].

A striking example of functional RNA structure comes from a study on small nucleolar RNAs in Leishmania. The authors demonstrated that a specific snoRNA dictates the structure and function of translating ribosomes, highlighting how RNA structural elements can modulate protein synthesis at a global level [7]. Similarly, long noncoding RNAs (lncRNAs) implicated in atherosclerosis exert their effects through conserved structural domains that recruit protein complexes, as reviewed in a recent pharmacological study [10]. These examples underscore that RNA structure is not static but dynamically regulated.

Decision Points When Analyzing RNA Structure

Before beginning a structural analysis, you must decide on the level of detail needed and the type of data available. Key decision points include:

1. What is the question? Are you predicting secondary structure to find conserved motifs, modeling tertiary structure for drug docking, or validating a proposed fold experimentally?
2. What input data exist? A single sequence, a multiple sequence alignment, experimental probing data (e.g., SHAPE, DMS), or a known homologous structure?
3. What computational resources are available? Thermodynamic folding algorithms (e.g., RNAfold) are fast for short sequences, comparative methods require alignment depth, machine learning approaches need training data.
4. How will you validate the model? Experimental validation (chemical probing, mutagenesis) or cross referencing with related structures in the PDB.
5. What are the limits of interpretation? Secondary structure predictions are less reliable for long RNAs (>1000 nt) and in regions with many alternative folds. Tertiary modeling is approximate without experimental constraints.

A practical workflow should account for these decisions and incorporate iterative refinement. The decision to use a single sequence versus a comparative approach depends on the sequence conservation: alignments of homologous RNAs dramatically improve prediction accuracy.

Workflow for RNA Structural Analysis

The following sequence of steps provides a practical implementation for analyzing RNA structure from sequence to functional hypothesis.

Step 1: Obtain and curate the RNA sequence. Retrieve the RNA sequence of interest from public databases such as NCBI or Ensembl. If using high throughput data, the NCBI Sequence Read Archive (SRA) is a primary repository for RNA sequencing reads that can be assembled into transcript sequences [5]. In some cases, complete genomes (e.g., mitochondrial genomes) are assembled and their RNA transcripts are annotated, as shown in a recent study of Ligusticum chuanxiong mitochondrial genome [6].

Step 2: Predict secondary structure. Use a thermodynamic folding algorithm such as RNAfold (ViennaRNA package) or mfold. Input the RNA sequence and examine the minimum free energy (MFE) structure, the partition function, and the ensemble of suboptimal folds. For alignments, use RNAalifold or similar tools that incorporate covariation information. Galaxy Training Network tutorials provide step by step instructions for running these tools [3].

Step 3: Visualize and inspect the predicted structure. Plot the secondary structure using VARNA or forna. Look for conserved stem loops, pseudoknots, and functional motifs. Compare your prediction with known RNA families from Rfam if available. The Bioconductor package R4RNA can automate some visualization and comparison tasks [4].

Step 4: Incorporate experimental constraints if available. Chemical probing data (e.g., SHAPE reactivity) can be used to restrain or filter secondary structure predictions. Tools like RNAstructure accept reactivity data to refine the fold. If you have cryo EM or X ray crystallography data, use that to guide model building.

Step 5: Build a tertiary model (optional). If the RNA is short (<200 nt) and a structural model is needed, use a fragment assembly method (e.g., SimRNA, Rosetta) or comparative modeling based on a known homologous structure. For longer RNAs, tertiary modeling is more speculative and should be interpreted with caution. For drug discovery applications, such as finding allosteric inhibitors of viral RNA dependent RNA polymerase, careful docking into structural models can be pursued, as demonstrated in a computational study on DENV 3 [11].

Step 6: Validate and iterate. Check the model against known biochemical data. Perform mutagenesis experiments to test predicted base pairing or ligand binding. If predictions fail, revisit the sequence quality or alignment and adjust parameters.

Quality Checks and Validation

Quality control is essential throughout the workflow. For secondary structure predictions, verify that the MFE structure is not drastically different from suboptimal folds. Use the centroid structure (from partition function) as a more robust alternative. Compare multiple prediction methods (e.g., RNAfold vs. RNAstructure) to see if they agree. For alignments, ensure the alignment is accurate and includes enough sequences to detect covariation.

When using experimental data, check that probing reagents target accessible nucleotides and that controls are included. Cross reference your predicted structure with known RNA motifs in databases like RNAcentral or the Protein Data Bank. A strong validation is to demonstrate that mutations disrupting a predicted stem loop also abrogate function, as seen in functional studies of snoRNAs [7].

For tertiary models, compute model quality scores (e.g., MolProbity, QMEAN) and compare to known structures of similar size. Be aware that low resolution models (from cryo EM at 4 6 Angstroms) may not resolve fine details. The study on tau liquid liquid phase separation highlights how RNA can influence protein aggregation, and such systems require careful structural interpretation because RNA and protein interactions are dynamic [9].

Common Mistakes

1. Overinterpreting a single MFE structure. RNA molecules are dynamic and often exist as an ensemble of conformations. Always examine alternative folds.
2. Using default parameters without checking. Thermodynamic parameters are temperature and salt dependent. Adjust accordingly for cellular conditions.
3. Ignoring pseudoknots. Standard folding algorithms often exclude pseudoknots. Use dedicated tools (e.g., pknotsRG) if they are biologically relevant.
4. Applying secondary structure prediction to very long RNAs without domain decomposition. Break the sequence into functional domains (e.g., <500 nt) and predict each separately.
5. Neglecting to validate with experimental data. Computational predictions alone are hypotheses, not facts. Whenever possible, test with chemical probing or mutational analysis.

Limits and Uncertainty

Secondary structure prediction accuracy decreases for sequences longer than about 1000 nucleotides due to computational complexity and the increasing number of alternative folds. Comparative methods improve accuracy but require a sufficiently diverse alignment. Tertiary structure prediction remains challenging, current methods can produce reasonable models for small RNAs (<150 nt) but are unreliable for larger ones without experimental constraints. Cryo EM and NMR provide higher resolution but are resource intensive and not applicable to all RNAs.

Another limit is that many functional RNAs interact with proteins, small molecules, or other RNAs, and these interactions can alter the structure. Structural models often ignore the cellular environment (e.g., crowding, ionic conditions, post transcriptional modifications). The study of lncRNAs in atherosclerosis notes that structural motifs in these RNAs are often evolutionarily conserved but their precise conformational dynamics are poorly understood [10]. Similarly, the role of RNA in tau phase separation involves complex, multivalent interactions that are difficult to capture in a single structural model [9].

Interpretation of structural data should always be tempered by these uncertainties. A predicted structure is a working hypothesis, not a solved structure. When used in drug design, such as targeting the DENV 3 RNA dependent RNA polymerase, in silico predictions must be confirmed by experimental binding and functional assays [11].

Frequently Asked Questions

Q1: What is the difference between primary, secondary, and tertiary RNA structure?
Primary structure is the linear nucleotide sequence. Secondary structure consists of local base paired regions forming stems and loops. Tertiary structure is the three dimensional folding of the entire molecule, stabilized by long range contacts. Each level builds on the previous one.

Q2: How do I predict RNA secondary structure from a sequence?
Use thermodynamic folding algorithms such as RNAfold (ViennaRNA) or mfold. Input the RNA sequence in FASTA format, run the tool, and inspect the minimum free energy structure. For better accuracy, also compute the partition function and examine the centroid structure. Tutorials from the Galaxy Training Network can guide you through the process [3].

Q3: Can RNA structure be determined without experiments?
Computational predictions are useful but cannot guarantee the correct in vivo structure. Experimental methods like SHAPE, DMS probing, or hydroxyl radical footprinting provide constraints that make predictions more reliable. For high resolution, cryo EM, X ray crystallography, or NMR are needed.

Q4: Why is RNA structure important for drug discovery?
Many viral RNAs (e.g., dengue virus, HIV) contain structured elements essential for replication. Targeting these structures with small molecules or oligonucleotides can inhibit viral function. The computational discovery of allosteric inhibitors for DENV 3 RNA dependent RNA polymerase illustrates this approach [11]. Structure based drug design requires accurate RNA structural models.

References and Further Reading

• NCBI Bookshelf. RNA structure and function overview. NCBI Bookshelf
• EMBL EBI Training. RNA structure bioinformatics tutorials. EMBL EBI Training
• Galaxy Training Network. RNA secondary structure prediction workflows. Galaxy Training Network
• Bioconductor. RNA analysis packages including R4RNA and RNAfold. Bioconductor
• NCBI Sequence Read Archive. Repository for RNA sequencing data. NCBI SRA
• Assembly of the complete mitochondrial genome of Ligusticum chuanxiong and its evolutionary implications. BMC Genomics. PubMed
• A small nucleolar RNA dictates the structure and function of translating ribosomes in Leishmania. Nat Commun. PubMed
• Beyond Lipid Lowering: Targeting lncRNAs as a Novel Therapeutic Strategy for Vascular Wall Defense in Atherosclerosis. Pharmacol Res. PubMed
• Computational discovery of DENV 3 RdRp allosteric inhibitors: biological evaluation and mechanistic studies. Mol Divers. PubMed
• Liquid liquid phase separation of tau in Alzheimer s disease. Int Rev Neurobiol. PubMed

Related Articles

• Somatic Cell
• Phases In Cell Cycle
• Endoplasmic Reticulum Cell Function
• Stages Of Cell Cycles
• Pcr Test